Personalized Disease Management
 
 
We understand that every patient is unique and individualized treatment is desirable. We strive to help physicians improve diagnostic accuracy and to optimize your patients’ disease management through personalized therapy. Our passion is to contribute to the understanding of the disease and the somatic responses to it, and in slowing and ultimately preventing the progression of Multiple Sclerosis and its associated disabilities.

To address the unmet needs of the MS treating and patient community, Glycominds offers diagnostic and prognostic tests that can contribute additional information to help guide treatment decisions for patients with Multiple Sclerosis.
 
 
News & Events
New Results to be Presented at AAN 2012
Come see what's new at the Glycominds exhibit at the 2012 American Academy of Neurology Annual Meeting in New Orleans!
April 23-27, 2012
Be sure to stop by the Glycominds Inc. booth #255.
We will be presenting poster titled, "gMS-Classifier1 Serum Assay is Associated with Faster Relapsing-Remitting Multiple Sclerosis (RRMS) Disability."
Tuesday, April 24th, from 7:30AM to 12:00PM. Poster # P02.092


Blood tests for Multiple Sclerosis
www.gms.net
IVD kits for individualized risk assessment of complicated Crohn's Disease patients
www.ibdx.net
Site Map | Privacy Policy | Contact Us
© 2012 Glycominds Ltd. All Right Reserved